By supplying high‑quality intermediates, we position ourselves as an essential part of the pharmaceutical value chain, supporting the efficient synthesis of active pharmaceutical ingredients.
We are committed to delivering the best quality intermediates, backed by strict adherence to all regulatory requirements. Every stage of production is fully traceable, with processes carefully documented and monitored to guarantee transparency, compliance, and consistency.
Our manufacturing is supported by complete quality controls, ensuring that each intermediate meets the highest standards of safety and performance. Through this combination of innovation, regulatory rigor, and uncompromising quality, we provide products that empower our customers and contribute meaningfully to the advancement of global healthcare.
| Apixaban | |
|---|---|
| 1-(4-Nitrophenyl)piperidin-2-one | 38560-30-4 |
| 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 503615-03-0 |
| (1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone) | 1267610-26-3 |
| Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate | 27143-07-3 |
| 5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone | 545445-44-1 |
| Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 503614-91-3 |
| Rivaroxaban | |
| R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione | 446292-07-5 |
| (S)-2-((2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione | 446292-08-6 |
| (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | 898543-06-1 |
| EdoxabanTosylate | |
| tert-Butyl (1R,2S,5S)-5-(dimethylcarbamoyl)-2-aminocyclohexylcarbamate oxalate | 1210348-34-7 |
| Ethyl (5-chloropyridin-2-ylcarbamoyl) formate | 349125-08-2 |
| Ethyl (5-chloropyridin-2-ylcarbamoyl) formate Hydrochloride | 1243308-37-3 |
| 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c] pyridine-2-carboxylic acid hydrochloride | 720720-96-7 |
| tert-Butyl (1R,2S,5S)-2-(2-(5-chloropyridin-2-ylamino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexylcarbamate | 480452-36-6 |
| N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-ethanediamide | 480449-70-5 |
| Escitalopram Oxalate | |
| (S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-benzonitrile Di-p-toluoyl-D-tartrate Salt (2:1) | 128173-53-5 |
| Atomoxetine HCl | |
| Atomoxetine Free Base | 83015-26-3 |
| Atomoxetine Mandelate | 131727-12-8 |
| Ivacaftor | |
| 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid. | 13721-01-2 |
| Ethyl 4-oxo-1,4-dihydroquinoline-3-carboxylate | 52980-28-6 |
| Acetamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]- | 1992813-92-9 |
| 5-Amino-2,4-di-tert-butylphenol | 873055-58-4 |
| Resmetirom | |
| Ethyl -(2-cyano-2-(2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)hydrazineylidene)acetyl)carbamate | 920509-33-7 |
| Xanomeline Tartrate | |
| 3-(4-(Hexyloxy)-1,2,5-thiadiazol-3-yl)-1-methylpyridinium iodide | 131888-19-7 |
| Xanomeline Fumarate | 161526-06-3 |